Anti-LXR beta antibody - ChIP Grade (ab56237)

Publishing research using ab56237? Please let us know so that we can cite the reference in this datasheet.

ab56237 has been referenced in 7 publications.

  • McDonald G  et al. Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients. J Clin Invest 124:712-24 (2014). Human . PubMed: 24463447
  • Feldmann R  et al. Genome-wide analysis of LXRa activation reveals new transcriptional networks in human atherosclerotic foam cells. Nucleic Acids Res 41:3518-31 (2013). WB, ChIP ; Human . PubMed: 23393188
  • Hu C  et al. LXRa-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells. Oncogene N/A:N/A (2013). PubMed: 23812424
  • Mogilenko DA  et al. Modified low density lipoprotein stimulates complement C3 expression and secretion via liver X receptor and Toll-like receptor 4 activation in human macrophages. J Biol Chem 287:5954-68 (2012). WB ; Human . PubMed: 22194611
  • Mogilenko DA  et al. PPAR? activates ABCA1 gene transcription but reduces the level of ABCA1 protein in HepG2 cells. Biochem Biophys Res Commun 402:477-82 (2010). WB, ICC/IF, ChIP, IP ; Human . PubMed: 20951680
  • Orlov SV  et al. Effect of TNFalpha on activities of different promoters of human apolipoprotein A-I gene. Biochem Biophys Res Commun 398:224-30 (2010). ChIP ; Human . PubMed: 20599735
  • Mogilenko DA  et al. Role of the nuclear receptors HNF4 alpha, PPAR alpha, and LXRs in the TNF alpha-mediated inhibition of human apolipoprotein A-I gene expression in HepG2 cells. Biochemistry 48:11950-60 (2009). ChIP ; Human . PubMed: 19883121

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"